Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium falciparum 80S ribosomal subunit (Pf80S) is the cytoplasmic ribosome of the malaria parasite P. falciparum, responsible for protein synthesis during its asexual blood stage. As in other eukaryotes, it consists of two subunits: the small 40S and large 60S subunits. However, Pf80S displays unique structural features that distinguish it from human and yeast ribosomes, making it an attractive target for antimalarial drug development. Several antimalarial drugs act by targeting this complex; for example, emetine binds within the E-site cleft, and mefloquine directly binds within the GTPase-associated center. These findings enable rational design of new derivatives with improved efficacy based on structure–activity relationships.
Inhibition of protein synthesis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum 80S Ribosomal Subunit (Pf80S).